A nationwide rollout of newborn spinal muscular atrophy (SMA) screening in England is starting an evaluation phase this October, with full UK implementation targeted by 2027.

Experts say early diagnosis enables timely treatment and can alter disease progression, with charities noting the potential to transform families’ lives.

Nelson warned that initial rollout would cover about 72% of England, raising concerns about a postcode lottery before nationwide coverage.”

Public figures like Cat Deely and Georgia Harrison voiced support for the rollout, reflecting broad public endorsement.

Despite criticism of a potential postcode lottery, officials argue the move reduces delayed diagnosis and helps families access earlier treatment.

SMA can severely affect motor function and breathing, but screening at birth could lead to longer, healthier lives for affected children.

Public pressure is acknowledged, and officials say there is a duty to ensure every child benefits from the testing expansion.

Health Secretary emphasized that earlier diagnosis could prevent loss of movement or breathing difficulties and improve outcomes.

Nelson’s social post framed the milestone, noting a staged rollout: seven sites from October 2026 and remaining sites by October 2027.

Health Secretary stressed expanding screening to reduce health inequalities and give babies across England the best chance at a healthy life.

At Great Ormond Street Hospital, twins undergo quarterly motor neuron assessments to monitor progression and determine if further treatment is needed, illustrating ongoing uncertainty.

Families like Ocean and Story, diagnosed early and treated with gene therapy, illustrate life-changing potential while noting the need for early diagnosis to maximize outcomes.